
ABDALLAH ALABADLA REMEMBERS THE NIGHT HE thought he was going to die. The college student had fled his home in Gaza City for Khan Younis, a place he thought would be safer. But soon after arriving, he found the city emptied of critical medical supplies.
"I went to every pharmacy in the area where I was staying, desperately looking for insulin," he said in a phone interview from Cairo, where he evacuated in March. "I thought I was going to die because I didn't find it. I don't know how to describe it. It was a horrible moment."
Alabadla, 23, was in his final semester at Al-Aqsa University, where he studied English literature before the October 7 attacks on Israel by Hamas and subsequent Israeli invasion of Gaza. He also has Type 1 diabetes and relies on taking insulin daily to stay alive.
Before the launch of Israel's offensive seeking to release the Israeli hostages and destroy Hamas, United Nations bodies estimated that up to 71,000 Palestinians in Gaza were living with diabetes as of November 2023. It is not known now how many of them have since fled or been killed.
Insulin is one of the medicines in "acute shortage" in Gaza, according to the World Health Organization, recalling a time before the advent of insulin therapy, when having diabetes-today considered a treatable condition almost always meant a death sentence within a matter of days or weeks.
Alabadla and others say they have gone to extreme measures to survive the shortage. They now frequently switch between multiple types of insulin based on availability rather than what is recommended for their unique needs, use expired insulin or resort to insulin rationing-a potentially fatal practice.
Dr. Waseem Alzaanin is a physician in Deir al-Balah, in central Gaza. Like Alabadla, he has Type 1 diabetes.
この記事は Newsweek US の August 02 - 09, 2024 (Double Issue) 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Newsweek US の August 02 - 09, 2024 (Double Issue) 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン

Slimmer Side Effects
Weight-loss drugs have become hugely popular but can cause gastrointestinal issues. A breakthrough could be about to change that and also make treatment more affordable

AMERICA'S BEST NEW PRODUCTS 2025
VERY YEAR, COMPANIES PUSH THE BOUNDARIES OF CREATIVity and develop new products that promise to make your life healthier, more convenient and more fun.

HIGH WIRE ACT
FAULTY POWER LINES AND ELECTRICAL EQUIPMENT ARE BEING BLAMED FOR CAUSING DEADLY FIRES IN LOS ANGELES AND ACROSS THE U.S. IS ENOUGH BEING DONE TO PREVENT THESE DEVASTATING BLAZES?

Chelsea Handler
AS A SIX-TIME NEW YORK TIMES BESTSELLING AUTHOR, CHELSEA HANDLER knows the secret to a successful book is to stay true to herself.

Stephen Amell
WHILE IT SEEMED LIKE EVERYONE ON SOCIAL media was binge-watching Suits during the pandemic, there was one person who was intentionally not watching the long-running series that ended in 2019: Stephen Amell.

Not Seeing...But Believing
How COVID reshaped our understanding of invisible air particles and the spread of disease

The Strongman of Ecuador
Daniel Noboa's bravado, aggressive policies and alignment with Trumpian politics has positioned him as a formidable figure in Latin America. But his fight to retain the presidency isn't over

Spheres of Influence
Donald Trump is channeling the great power politics of past centuries to deal with China and Russia, experts tell Newsweek

AMERICA'S BEST LOYALTY PROGRAMS 2025
LOYALTY PROGRAMS HAVE BECOME A CORNERSTONE of the modern shopping experience, offering perks and rewards designed to keep customers returning for more.

Winning the Global Game
The U.S. holds more cards than China. Whether we keep our strategic advantage depends on how we play our hand